Keytruda+Lenvima – Flight 2- RCC Display Banners Therapeutic Spotlight – 23210
Who Benefits Most from Multidisciplinary Evaluations at Renal Cell Carcinoma Diagnosis?
Jun 9, 2022
For patients with renal cell carcinoma (RCC), a multidisciplinary team (MDT) approach, along with...
No Survival Benefit With Cytoreductive Nephrectomy for Clear Cell Renal Cell Carcinoma
Jun 6, 2022
Metastatic clear cell renal carcinoma (ccRCC) is the most common type of kidney cancer....
Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
May 2, 2022
To conduct a cost-effectiveness analysis of stereotactic body radiotherapy (SBRT) versus radiofrequency ablation (RFA) in the non-surgical management of early stage renal cell carcinoma (RCC) according to Consolidated Health...
Isolated pituitary metastasis of renal cell carcinoma: A case report and systematic review of the literature.
May 2, 2022
Background- Isolated pituitary gland metastasis is an extremely rare event in renal cell carcinoma. We present a unique case of isolated pituitary metastasis of renal cell carcinoma and a systematic review of literature. Case...
Incidence & Distribution of New RCC Cases: 27-Year Trends from a Statewide Cancer Registry
Apr 29, 2022
Renal cell carcinoma was becoming more common, according to national databases (RCC). Over 27...
Renal Cell Carcinoma (RCC) Has a High Level of PD-L1+ & Hyal2+ Myeloid-derived Suppressor Cells
Apr 29, 2022
Patients with renal cell carcinoma (RCC) had increased immunosuppressive myeloid cells in their...
For Patients with mRCC, Metastasectomy May Offer OS Benefit
Apr 27, 2022
Recent findings support the notion of metastasectomy being linked with an overall survival (OS)...
Nomogram Model Can Help Predict Early Death in mRCC
Apr 26, 2022
A nomogram statistical model may play a major role in predicting the early death of patients with...
